RT @ChanceGardiner: Nature, 2015: "La biotecnologia da un miliardo di dollari. Moderna ha grandi ambizioni. Come una neonata start-up è…
RT @ChanceGardiner: Nature, 2015: "La biotecnologia da un miliardo di dollari. Moderna ha grandi ambizioni. Come una neonata start-up è…
RT @ChanceGardiner: Nature, 2015: "La biotecnologia da un miliardo di dollari. Moderna ha grandi ambizioni. Come una neonata start-up è…
RT @ChanceGardiner: Nature, 2015: "La biotecnologia da un miliardo di dollari. Moderna ha grandi ambizioni. Come una neonata start-up è…
RT @ChanceGardiner: Nature, 2015: "La biotecnologia da un miliardo di dollari. Moderna ha grandi ambizioni. Come una neonata start-up è…
RT @ChanceGardiner: Nature, 2015: "La biotecnologia da un miliardo di dollari. Moderna ha grandi ambizioni. Come una neonata start-up è…
Nature, 2015: "La biotecnologia da un miliardo di dollari. Moderna ha grandi ambizioni. Come una neonata start-up è diventata una delle aziende farmaceutiche private più apprezzate di sempre." https://t.co/1hbuFCvqaq
The Billion Dollar Biotech https://t.co/atsgKfj9EK https://t.co/HJP45GnaH5
@sweetcathie More on the back story, also from ELie Dolgin... https://t.co/atsgKfj9EK
RT @luigi_warren: On Moderna backstory, recommended reading #1: https://t.co/atsgKfj9EK
RT @luigi_warren: On Moderna backstory, recommended reading #1: https://t.co/atsgKfj9EK
RT @luigi_warren: On Moderna backstory, recommended reading #1: https://t.co/atsgKfj9EK
RT @luigi_warren: On Moderna backstory, recommended reading #1: https://t.co/atsgKfj9EK
RT @luigi_warren: On Moderna backstory, recommended reading #1: https://t.co/atsgKfj9EK
On Moderna backstory, recommended reading #1: https://t.co/atsgKfj9EK
RT @kkariko: Business: The billion-dollar biotech https://t.co/5Q0wnSS9Ge
RT @luigi_warren: @RebeccaWeisser Although this long pre-dates the COVID-19 era, I strongly recommend Elie Dolgin's article (below) from th…
RT @luigi_warren: @RebeccaWeisser Although this long pre-dates the COVID-19 era, I strongly recommend Elie Dolgin's article (below) from th…
RT @luigi_warren: @RebeccaWeisser Although this long pre-dates the COVID-19 era, I strongly recommend Elie Dolgin's article (below) from th…
RT @luigi_warren: @RebeccaWeisser Although this long pre-dates the COVID-19 era, I strongly recommend Elie Dolgin's article (below) from th…
@RebeccaWeisser Although this long pre-dates the COVID-19 era, I strongly recommend Elie Dolgin's article (below) from the early years of Moderna. Indeed, the fact that it was written pre COVID makes it more objective in some ways. https://t.co/atsgKfj9EK
RT @luigi_warren: @SergiuBrasovanu @RWMaloneMD See also this older but very good article on Moderna: https://t.co/atsgKfj9EK
@SergiuBrasovanu @RWMaloneMD See also this older but very good article on Moderna: https://t.co/atsgKfj9EK
RT @o_ob: そしてmRNAの可能性に注目しModerna Therapeuticsが設立された。 Business: The billion-dollar biotech (2015) https://t.co/inr1XXcO9U
RT @luigi_warren: @nay_sue1 Salesmanship https://t.co/Pvr2obFDfd https://t.co/QHBI3RIssR
RT @luigi_warren: @nay_sue1 Salesmanship https://t.co/Pvr2obFDfd https://t.co/QHBI3RIssR
The billion-dollar biotech #BioTech via https://t.co/r12ZQ2CSWN https://t.co/c021jpir5L
The billion-dollar biotech #BioTech via https://t.co/hmIoXfIspy https://t.co/KsvaX4teno
RT @luigi_warren: @nay_sue1 Salesmanship https://t.co/Pvr2obFDfd https://t.co/QHBI3RIssR
RT @luigi_warren: @nay_sue1 Salesmanship https://t.co/Pvr2obFDfd https://t.co/QHBI3RIssR
RT @o_ob: そしてmRNAの可能性に注目しModerna Therapeuticsが設立された。 Business: The billion-dollar biotech (2015) https://t.co/inr1XXcO9U
@nay_sue1 Salesmanship https://t.co/Pvr2obFDfd https://t.co/QHBI3RIssR
RT @o_ob: そしてmRNAの可能性に注目しModerna Therapeuticsが設立された。 Business: The billion-dollar biotech (2015) https://t.co/inr1XXcO9U
そしてmRNAの可能性に注目しModerna Therapeuticsが設立された。 Business: The billion-dollar biotech (2015) https://t.co/inr1XXcO9U
RT @BasbugGokce: Aşıda patent yok diyenler, patentin kalkmasını talep edenleri atıp tutmakla suçlayanlar aylar önce paylaştığım bu 2015 tar…
RT @BasbugGokce: Aşıda patent yok diyenler, patentin kalkmasını talep edenleri atıp tutmakla suçlayanlar aylar önce paylaştığım bu 2015 tar…
Aşıda patent yok diyenler, patentin kalkmasını talep edenleri atıp tutmakla suçlayanlar aylar önce paylaştığım bu 2015 tarihli Nature makalesini okusunlar. Bu makale ta 2010 yılında başlayan mRNA patent savaşlarını anlatıyor👇
company. https://t.co/LqsDVk2KVu In an interview with the Washington Post, Weissman said of the current producers of the Covid vaccines, “They’re using the technology that [Kariko] and I developed,” he said. “We feel like it’s our vaccine, and we are incr
RT @luigi_warren: 2/ Dolgin contact contributing to his excellent, well-researched 2015 article for Nature, The Billion Dollar Biotech. Of…
2/ Dolgin contact contributing to his excellent, well-researched 2015 article for Nature, The Billion Dollar Biotech. Of the more recent contacts, most seem to be oriented to long-form pieces and the only https://t.co/Pvr2obFDfd
RT @luigi_warren: @Fifi_Borgia @JamesDelingpole Thanks. To be clear I have not worked on the mRNA vaccines or for Moderna. Derrick Rossi, m…
@Fifi_Borgia @JamesDelingpole Thanks. To be clear I have not worked on the mRNA vaccines or for Moderna. Derrick Rossi, my former boss, founded Moderna on the strength of my breakthrough work on using synthetic mRNA to "reprogram" ordinary cells into stem
Te lees esto de Nature en 2015 https://t.co/5YJJ8n8ngT. Estudias qué es eso del RNAm y por qué puede cambiar el mundo. En 2018 inviertes en una empresa cuyo ticker es $MRNA y en un par de años multiplicas por 10 tu inversión. Fácil! verdad?
RT @BasbugGokce: Pandemiden yıllar önce Moderna henüz hiç bir ürün piyasaya sürmemişken, kayda değer bilimsel yayın yapmamışken kasasına mi…
RT @BasbugGokce: Pandemiden yıllar önce Moderna henüz hiç bir ürün piyasaya sürmemişken, kayda değer bilimsel yayın yapmamışken kasasına mi…
RT @BasbugGokce: Pandemiden yıllar önce Moderna henüz hiç bir ürün piyasaya sürmemişken, kayda değer bilimsel yayın yapmamışken kasasına mi…
Pandemiden yıllar önce Moderna henüz hiç bir ürün piyasaya sürmemişken, kayda değer bilimsel yayın yapmamışken kasasına milyar doları doldurmuş. 2015 tarihli bu Nature makalesinde ayrıntıları, daha o zaman başlayan patent savaşlarını okuyabilirsiniz. (4) h
@DrAntoniSerraT1 Absolutely. See this article for more background on the rise of mRNA... https://t.co/Pvr2obFDfd
@benmagelsen @KevinMcH3 This is a good article on the background... https://t.co/Pvr2obFDfd
@KevinMcH3 @DrEricDing I am afraid some mythologizing is going here, yes. Not sure how much of this is just the reporter. This is a good early article on Moderna: https://t.co/Pvr2obFDfd
RT @kkariko: Business: The billion-dollar biotech https://t.co/5Q0wnSS9Ge
@HeatherEHeying @BretWeinstein If possible, would be good to see a discussion with Luigi Warren to expand details of the mRNA approach. https://t.co/tVYYtl7VpT
How does a future Nobel prize winner for mRNA (@BioNTech_Group senior vp research @kkariko) get fired from a tenured position by a top research University such as @upenn? Why is no one digging and telling this fascinating story @deanbaquet @khalafroula @K
@andrewbostom @statnews Here's a useful early article on Moderna: https://t.co/Pvr2obFDfd
RT @tS0u: Γενικά τα όσα ξεχωρίζουν την Moderna από τις εταιρείες του κλάδου σχεδόν δεν τελειώνουν. Το βασικότερο είναι η μυστικοπάθεια σχε…
RT @tS0u: Γενικά τα όσα ξεχωρίζουν την Moderna από τις εταιρείες του κλάδου σχεδόν δεν τελειώνουν. Το βασικότερο είναι η μυστικοπάθεια σχε…
RT @tS0u: Γενικά τα όσα ξεχωρίζουν την Moderna από τις εταιρείες του κλάδου σχεδόν δεν τελειώνουν. Το βασικότερο είναι η μυστικοπάθεια σχε…
Γενικά τα όσα ξεχωρίζουν την Moderna από τις εταιρείες του κλάδου σχεδόν δεν τελειώνουν. Το βασικότερο είναι η μυστικοπάθεια σχετικά με τα πάντα. Το δεύτερο ωστόσο είναι πιο ενδιαφέρον: Είναι η φαρμακευτική που έχει μόλις έναν γιατρό στο ΔΣ της. 8/ http
RT @luigi_warren: @steveetienne3 @Mr_B_OB @DuncanBannatyne @maryskaron @JamesDelingpole @WilliamHaveron Moderna was founded by my old boss…
@steveetienne3 @Mr_B_OB @DuncanBannatyne @maryskaron @JamesDelingpole @WilliamHaveron Moderna was founded by my old boss based on my work. I'm not a vaccine expert but I do know a thing or two about mRNA. https://t.co/Pvr2obFDfd
Business: The billion-dollar biotech (2015) https://t.co/lS2kRZ3Bie
RT @Medtech_LaForge: Business: The billion-dollar biotech : Nature News & Comment #RNA #sequencing_DNA #genetic_profile #sequencing_RNA vi…
Business: The billion-dollar biotech : Nature News & Comment #RNA #sequencing_DNA #genetic_profile #sequencing_RNA via @owhy3 @wofford_liz https://t.co/8ZMKOHXtSF
Rush for the Vaccine of the Century, Trump’s budget 50B for R&D promising companies
RT @owhy3: https://t.co/Jj8OkqRD43 https://t.co/SQq271K0G1 The billion-dollar biotech a #RNA based thertapeutics #sequencing_DNA gives a…
The Big Business!
RT @owhy3: https://t.co/Jj8OkqRD43 https://t.co/SQq271K0G1 The billion-dollar biotech a #RNA based thertapeutics #sequencing_DNA gives a…
https://t.co/Jj8OkqRD43 https://t.co/SQq271K0G1 The billion-dollar biotech a #RNA based thertapeutics #sequencing_DNA gives a #genetic_profile of an organism, #sequencing_RNA reflects only the sequences that are actively expressed in the cells. #Modern
Business: The billion-dollar biotech https://t.co/T6O6YMF3S3
RT @bmaher: .@antonioregalado @matthewherper It doesn't stray terribly far from what @eliedolgin found https://t.co/bfgzjVfiaI
.@antonioregalado @matthewherper It doesn't stray terribly far from what @eliedolgin found https://t.co/bfgzjVfiaI
Dare I ask what @JohnCendpts thought of my June 2015 story on @Moderna_Tx in @NatureNews? https://t.co/QGiQteUC2s https://t.co/vs86Gbxkh2
The newest billion-dollar #biotech : How a company With only one drug in development signed a deal for $420 Million https://t.co/hEfTaKDRzT
RT @heidiledford: What does Moderna do again? For nice refresher in wake of AZN investment, see excellent profile by @ElieDolgin https://t…
What does Moderna do again? For nice refresher in wake of AZN investment, see excellent profile by @ElieDolgin https://t.co/ZIkR3kA0ug
Stephane Bancel still not addressing the Kariko patent for mRNA therapeutics: https://t.co/zXSZHmQZtb @ldtimmerman https://t.co/QGiQteD1aU
Business: The billion-dollar biotech https://t.co/Caf7GamoA5
Business: The billion-dollar biotech https://t.co/16r1UGmpal
RT MSS_Limited: RT AttractCapital: How a tiny startup became the biggest, privately held drug company. Ever. #busi… https://t.co/wfiVP87uVD
RT MSS_Limited: RT BiotechStart: RT AttractCapital: How a tiny startup became the biggest, privately held drug com… https://t.co/wfiVP87uVD
RT @BiotechStart: RT AttractCapital: How a tiny startup became the biggest, privately held drug company. Ever. #businessgrowth https://t.co…
RT @AttractCapital: How a tiny startup became the biggest, privately held drug company. Ever. #businessgrowth https://t.co/phmeWbllsg
RT AttractCapital: How a tiny startup became the biggest, privately held drug company. Ever. #businessgrowth https://t.co/wfiVP87uVD
How a tiny startup became the biggest, privately held drug company. Ever. #businessgrowth https://t.co/phmeWbllsg
RT @Brainclinics: Interesting read on RNA-therapeutics: The billion-dollar biotech @Nature http://t.co/7DJzVl2ABg http://t.co/4uTZ9MF7Lz
Interesting read on RNA-therapeutics: The billion-dollar biotech @Nature http://t.co/7DJzVl2ABg http://t.co/4uTZ9MF7Lz
RT @InTheKnowCIO: The billion-dollar biotech: Moderna Therapeutics has big ambitions and a bankroll to match. - http://t.co/hHGUW3Rn40 http…
The billion-dollar biotech: Moderna Therapeutics has big ambitions and a bankroll to match. - http://t.co/hHGUW3Rn40 http://t.co/wbCnOCu274
Interesting: "Billion-dollar biotech: The start-up with big ambitions and a bankroll to match" http://t.co/4wFJybzies http://t.co/CPagmv4iz5
@RNAiAnalyst and since most players are either private or not disclosing, 1 never knows for sure #mRNA $TKMR http://t.co/iiAgnAFcJ4
@RNAiAnalyst and since most players are either private or not disclosing, 1 never knows for sure #mRNA $TKMR http://t.co/iiAgnAFcJ4
The billion-dollar biotech startup. http://t.co/B2sHWKLiIJ probably first of many to come